HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen.

Abstract
Nine patients with severe factor-VII deficiency, belonging to seven pedigrees were studied for the presence of factor-VII-CRM with an inhibitor neutralization assay. The antibody, raised in rabbits, did not precipitate the antigen and could only be used in a fluid phase assay to measure the capacity of plasma to neutralize inhibitory activity directed against factor-VII activity. In one of these nine patients normal amounts of factor-VII-CRM could be demonstrated. The CRM + patient did not show a clinical picture at variance with that of the CRM-patients. The investigation into this CRM+ pedigree revealed heterozygosity in nine out of 12 persons when using the ratio between biological factor-VII activity and factor-VII-CRM as the criterion.
AuthorsM G Mazzucconi, F Mandelli, G Mariani, E Briët, J J Veltkamp
JournalBritish journal of haematology (Br J Haematol) Vol. 36 Issue 1 Pg. 127-35 (May 1977) ISSN: 0007-1048 [Print] England
PMID871417 (Publication Type: Journal Article)
Chemical References
  • Antigens
  • Factor VII
Topics
  • Adolescent
  • Adult
  • Animals
  • Antigens (analysis)
  • Child
  • Cross Reactions
  • Factor VII (analysis, immunology)
  • Factor VII Deficiency (genetics, immunology)
  • Female
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Neutralization Tests
  • Pedigree
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: